Home
Home

Affymax

Affymax says considering all alternatives, including bankruptcy

Affymax says considering all alternatives, including bankruptcy
Yahoo/Fly on the Wall

FDA saw early reports of severe Omontys reactions: WSJ

FDA saw early reports of severe Omontys reactions: WSJ
Fierce Pharma

Affymax Will Rise Again

Affymax Will Rise Again
Seeking Alpha

Affymax may file for bankruptcy; cuts 75 percent of workforce

Affymax may file for bankruptcy; cuts 75 percent of workforce
Yahoo/Reuters

Amgen And The Biosimilar Threat: Lessons From Affymax

Amgen And The Biosimilar Threat: Lessons From Affymax
Seeking Alpha

Amgen Benefits From Affymax Recall

Amgen Benefits From Affymax Recall
Seeking Alpha

The Best- And Worst-Performing Biotech Stocks In February

The Best- And Worst-Performing Biotech Stocks In February
Forbes

This Week in Biotech

This Week in Biotech
Motley Fool

Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Affymax, Inc.

Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Affymax, Inc.
Yahoo/PR Newswire

Blood Drug Woes Could Weigh on FDA and its Approval of New, Copycat Biologic Medicines

Blood Drug Woes Could Weigh on FDA and its Approval of New, Copycat Biologic Medicines
Forbes